Dr. Gerd Michel obtained his PhD from the University of Heidelberg, Germany, where he was head of the Receptor Research Laboratory at the Dept. of Internal Medicine. After two years in the private laboratory sector he joined Abbott Laboratories as a founding member of their European Research unit, which increased from an initial 3 employees to an operation of >600 at the time he left Abbott.
He spent more than 18 years with Abbott Diagnostics rising to the post of Director of Medical and Scientific Development for Europe, Middle East & Africa. Among various management functions he also had responsibility for OEM product development and assessment of new technologies. Among his numerous product successes were HCV, HIV and cardiac Troponin I tests that became state of the art diagnostics worldwide.
He has held the position of STO at the Foundation of New Innovative Diagnostics (FIND) in Geneva, for more than 7 years. During this time he focused successfully on the discovery of novel biomarkers for use in point-of-care detection of infectious diseases such as tuberculosis and malaria, mainly funded by the Bill & Melinda Gates Foundation.
He has become Vice President of R&D and Chief Technology Officer at Vela Research in Singapore in 2013, focusing on molecular and personalized diagnostics.
He received several industry and academic awards for his work, has (co-) authored >180 peer-reviewed publications and is an internationally requested reviewer and speaker. He is also an inventor on a number of patents. He holds fellowships from the University of Aarhus, Denmark, and the German Cancer Research Centre. He has held a number of advisory posts, e.g. at WHO and the OECD. He served as a member of the German National Blood Advisory Board of the Ministry of Health and is currently a member of several international Research Funding Committees, e.g. at the Wellcome Trust, London, and the Global Health Innovation Fund, Tokyo, respectively.
In addition to his scientific career he completed business education at Northwestern University in Chicago and is an alumnus of IMD (International Management Development) Lausanne, Switzerland, two of the top rated international management schools.